Latest News About Vitamin K Deficiency

Here are the latest reliable updates on vitamin K deficiency and related bleeding risks.

• Key topic: Late-onset vitamin K deficiency bleeding (VKDB) remains a preventable cause of serious bleeding in infants when routine prophylaxis is incomplete or refused. Contemporary reviews emphasize that intramuscular vitamin K at birth offers the strongest protection, while oral regimens require strict adherence and may be less effective for late VKDB. This continues to be a public health focus in several countries where parental acceptance of IM vitamin K varies.[1]

• Guidelines and best practices: Clinical guidelines consistently recommend 1 mg of vitamin K given intramuscularly to all newborns at birth to prevent VKDB, with oral regimens as a secondary option if IM is refused; however, finishing the full prophylaxis course (often multiple oral doses) is crucial for sustained protection, particularly against late VKDB. NICE and other bodies have repeatedly supported IM vitamin K as the most reliable prophylaxis, noting higher failure rates with oral-only strategies in breastfed babies.[2]

• Recent clinical reports and reviews: A 2024 case report highlights the severe, multi-system risks of VKDB when prophylaxis is declined, reinforcing the need for ongoing education and informed consent discussions with caregivers about vitamin K administration in newborns. More comprehensive reviews from 2018–2025 summarize the mechanism, diagnosis, and management of VKD across age groups, including the critical role of prophylaxis and treatment when bleeding occurs (parenteral vitamin K for emergencies; substitution with blood products if severe).[9][1][2]

• Public health and news coverage: Reports and commentaries in major outlets have discussed the balance between parental choice, public health guidance, and neonatal safety, including cases where lack of routine vitamin K administration contributed to adverse outcomes; these discussions often reference the evidence base favoring IM prophylaxis and the need for safeguarding best practices in hospitals and birth centers.[3]

• Diagnostic and treatment updates: For suspected VKDB, immediate parenteral vitamin K is standard, with additional therapies such as four-factor prothrombin complex concentrate or fresh frozen plasma in severe cases; long-term management involves ongoing prophylaxis and monitoring of coagulation status. Reviews also cover neonatal risk factors in breastfed infants and the importance of universal birth prophylaxis to minimize VKDB incidence.[4][6][9]

Illustration

• A simple mental model: Vitamin K acts like a crucial “glue” that helps blood-clotting proteins become active. Without it at birth, some newborns can bleed severely; giving vitamin K IM at birth essentially glues the clotting system in place, while oral regimens require careful follow-up to achieve similar protection.[2]

If you’d like, I can pull the specific guideline texts from NICE and CDC or summarize the latest primary studies in a short table, or find country-specific recommendations for Prague/Czech Republic. I can also provide a brief patient‑facing handout explaining why vitamin K prophylaxis is recommended and what to expect at birth.